ЗВ''ЯЗОК СТРУКТУРНО-ГЕОМЕТРИЧНИХ ЗМІН ЛІВОГО ШЛУНОЧКА ТА ФУНКЦІОНАЛЬНИХ ВЛАСТИВОСТЕЙ ТРОМБОЦИТІВ У ХВОРИХ НА АРТЕРІАЛЬНУ ГІПЕРТЕНЗІЮ НИЗЬКОГО ТА ПОМІРНОГО ДОДАТКОВОГО РИЗИКУ ПІД ВПЛИВОМ ТЕРАПІЇ ЕПРОСАРТАНА МЕЗИЛАТОМ
This article represents the result of 6th week therapy with eprosartan mesylat 600 mg once a day. Eprosartan monotherapy decreased LV hypertrophy. On a background of this intromyocardial tension diminishes and the index of volume increases. Reliable influence on platelets functional activity was absent. During treatment correlation connection has been lost between level of systolic BP and PWLV, that testifies to the presence of eprosartan independent cardioprotective effect. Connection between the thickness of PWLV and aggregation degree also was lost. that testifies that there is no possibility of increased aggregation influence on hypertrophy development.